Trigeminal Neuralgia Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight
(Albany, US) DelveInsight has launched a new report on “Trigeminal Neuralgia – Market Insights, Epidemiology, and Market Forecast-2030“
DelveInsight’s “Trigeminal
Neuralgia – Market Insights, Epidemiology, and Market Forecast-2030“ report
delivers an in-depth understanding of the Trigeminal Neuralgia, historical and
forecasted epidemiology as well as the Trigeminal Neuralgia market trends in
the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and
Japan.
Some
of the Trigeminal Neuralgia facts:
- As
per the National Organization for Rare Disorders (NORD), trigeminal
neuralgia affects females slightly more often than males.
- The
exact incidence of trigeminal neuralgia is unknown, approximately
10,000–15,000 new cases occur each year in the United States.
- The
incidence of trigeminal neuralgia (TN) is 4.3 per 100,000 persons per
year.
Request for free sample page: https://www.delveinsight.com/sample-request/trigeminal-neuralgia-market
Scope
of the Trigeminal Neuralgia Report
- The
report covers the descriptive overview of Trigeminal Neuralgia, explaining
its causes, signs and symptoms, pathophysiology, diagnosis and currently
available therapies
- Comprehensive
insight has been provided into the Trigeminal Neuralgia epidemiology and
treatment in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for
Trigeminal Neuralgia are provided, along with the assessment of new
therapies, which will have an impact on the current treatment landscape
- A
detailed review of Trigeminal Neuralgia market; historical and forecasted
is included in the report, covering drug outreach in the 7MM
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the global Trigeminal Neuralgia
market
Request for free sample page: https://www.delveinsight.com/sample-request/trigeminal-neuralgia-market
Trigeminal Neuralgia Market
Trigeminal
Neuralgia (TN), also
known as tic douloureux, is a chronic pain condition that affects the
trigeminal or fifth cranial nerve, one of the most widely distributed nerves in
the head. Trigeminal Neuralgia is a form of neuropathic pain
(pain associated with nerve injury or nerve lesion).
Trigeminal neuralgia is categorized in two types: primary
(idiopathic) or secondary. The typical or “classic” form of the disorder
called Trigeminal Neuralgia 1 causes extreme, sporadic, sudden
burning or shock-like facial pain that lasts anywhere from a few seconds to as
long as two minutes per episode. These attacks can occur in quick succession,
in volleys lasting as long as two hours. The “atypical” form of the disorder called Trigeminal
Neuralgia 2 is characterized by constant aching, burning, stabbing
pain of somewhat lower intensity than Type 1. Both forms of pain may occur in
the same person, sometimes at the same time. The intensity of pain can be
physically and mentally incapacitating.
Request for free sample page: https://www.delveinsight.com/sample-request/trigeminal-neuralgia-market
Trigeminal
Neuralgia occurs most often in people over age 50, although it can
occur at any age, including infancy. The possibility of Trigeminal
Neuralgia being caused by multiple sclerosis increases when it occurs
in young adults. The incidence of new cases is approximately 12 per 100,000
people per year; the disorder is more common in women than in men.
Trigeminal Neuralgia is associated with a
variety of conditions. Trigeminal Neuralgia can be caused by a
blood vessel pressing on the trigeminal nerve as it exits the brain stem; this
compression causes the wearing away or damage to the protective coating around
the nerve (the myelin sheath). TN symptoms can also occur in people with
multiple sclerosis, a disease that causes deterioration of the trigeminal
nerve’s myelin sheath. Rarely, symptoms of Trigeminal Neuralgia may
be caused by nerve compression from a tumor, or a tangle of arteries and veins
called an arteriovenous malformation. Injury to the trigeminal nerve (perhaps
the result of sinus surgery, oral surgery, stroke, or facial trauma) may also
produce neuropathic facial pain.
Some of the Trigeminal
Neuralgia companies covered:
- Biogen
- Biohaven
Pharmaceuticals
- And
Many Others
Some of the Trigeminal
Neuralgia Drugs covered:
- Vixotrigine
(BIIB074)
- Rimegepant
- And
Many Others
Request for free sample page: https://www.delveinsight.com/sample-request/trigeminal-neuralgia-market
- Key
Insights
- Executive
Summary of Trigeminal Neuralgia
- Competitive
Intelligence Analysis for Trigeminal Neuralgia
- Trigeminal
Neuralgia: Market Overview at a Glance
4.1. Trigeminal Neuralgia Total Market Share (%)
Distribution in 2017
4.2. Trigeminal Neuralgia Total Market Share (%)
Distribution in 2030
- Trigeminal
Neuralgia: Disease Background and Overview
- Patient
Journey
- Trigeminal
Neuralgia Epidemiology and Patient Population
- Treatment
Algorithm, Current Treatment, and Medical Practices
- Unmet
Needs
- Key
Endpoints of Trigeminal Neuralgia Treatment
- Marketed
Products
List to be continued in report
- Emerging
Therapies
List to be continued in report
- Trigeminal
Neuralgia: Seven Major Market Analysis
- Attribute
analysis
- 7MM:
Market Outlook
- Access
and Reimbursement Overview of Trigeminal Neuralgia
- KOL
Views
- Market
Drivers
- Market
Barriers
- Appendix
- DelveInsight
Capabilities
- Disclaimer
Request for Detailed TOC: https://www.delveinsight.com/sample-request/trigeminal-neuralgia-market
About DelveInsight
DelveInsight is a leading Life Science market research and
business consulting company recognised for its off-the-shelf syndicated market
research reports as well as customised solutions to firms in the healthcare
sector.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment